Prognostic factors and treatment efficacy in patients with primary diffuse large B-cell lymphoma of the bone: single institute experience over 11 years. [electronic resource]
Producer: 20140912Description: 95-101 p. digitalISSN:- 1349-7235
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bone Neoplasms -- drug therapy
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Female
- Follow-Up Studies
- Hospitals, General -- statistics & numerical data
- Hospitals, Veterans -- statistics & numerical data
- Humans
- Kaplan-Meier Estimate
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Positron-Emission Tomography
- Prednisone -- administration & dosage
- Prognosis
- Radiotherapy, Adjuvant
- Remission Induction
- Retrospective Studies
- Rituximab
- Taiwan -- epidemiology
- Treatment Outcome
- Vincristine -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.